Form 8-K MARRONE BIO INNOVATIONS For: Aug 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Marine Bio (MBII) Reports In-Line Q2 EPS, Enters Microbial Product Development Pact with Albaugh
August 9, 2016 4:46 PM EDTMarine Bio (NASDAQ: MBII) reported Q2 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.61 million.
Albaugh, LLC and Marrone Bio Innovations, Inc. (MBI) announced the companies have signed an exclusive agreement to develop and market one of MBIs microbial products, a proprietary microbial biopesticide with insecticidal and nematicidal properties, for seed treatment applications.
Dr. Pam Marrone, Founder and... More
